Search research articles
Contact Us
Filters
Showing results (31-40 of 135) with videos related to
Page
of 14
Sort By:
American Journal of Alzheimer'S Disease and Other Dementias
|
April 16, 2010
Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease
Martin R Farlow, Jeffrey L Cummings, Jason T Olin, et al.
Nature
|
January 7, 2026
Surface optimization governs the local design of physical networks
Xiangyi Meng, Benjamin Piazza, Csaba Both, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
January 23, 2009
Long-term safety and tolerability of rivastigmine in patients with Alzheimer's disease switched from donepezil: an open-label extension study
Gary S Figiel, Barbara Koumaras, Xiangyi Meng, et al.
SAGE Open Medicine
|
January 16, 2016
Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease
Joseph L Micca, James E Galvin, Drew M Velting, et al.
Journal of Food Science and Technology
|
March 26, 2019
Effect of operating parameters on milling quality and energy consumption of brown rice
Xiangyi Meng, Fuguo Jia, Yawen Xiao, et al.
Elife
|
January 6, 2026
Rice stripe virus utilizes a <i>Laodelphax striatellus</i> salivary carbonic anhydrase to facilitate plant infection by direct molecular interaction
Jing Zhao, Xiangyi Meng, Jie Yang, et al.
Toxins
|
April 21, 2022
Protective Effects of Ferulic Acid on Deoxynivalenol-Induced Toxicity in IPEC-J2 Cells
Xiangyi Meng, Wenyan Yu, Nuo Duan, et al.
International Journal of Geriatric Psychiatry
|
February 20, 2014
Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis
Gustavo Alva, Richard Isaacson, Carl Sadowsky, et al.
International Journal of Geriatric Psychiatry
|
November 10, 2011
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy
Martin R Farlow, George T Grossberg, Xiangyi Meng, et al.
Dermatology (Basel, Switzerland)
|
May 30, 2019
Exploration of the Product of the 5-Point Investigator's Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis
Alice B Gottlieb, Rebecca Germino, Vivian Herrera, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 135) with videos related to
Sort By:
Page
of 14
American Journal of Alzheimer'S Disease and Other Dementias
|
April 16, 2010
Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease
Martin R Farlow, Jeffrey L Cummings, Jason T Olin, et al.
Nature
|
January 7, 2026
Surface optimization governs the local design of physical networks
Xiangyi Meng, Benjamin Piazza, Csaba Both, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
January 23, 2009
Long-term safety and tolerability of rivastigmine in patients with Alzheimer's disease switched from donepezil: an open-label extension study
Gary S Figiel, Barbara Koumaras, Xiangyi Meng, et al.
SAGE Open Medicine
|
January 16, 2016
Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease
Joseph L Micca, James E Galvin, Drew M Velting, et al.
Journal of Food Science and Technology
|
March 26, 2019
Effect of operating parameters on milling quality and energy consumption of brown rice
Xiangyi Meng, Fuguo Jia, Yawen Xiao, et al.
Elife
|
January 6, 2026
Rice stripe virus utilizes a <i>Laodelphax striatellus</i> salivary carbonic anhydrase to facilitate plant infection by direct molecular interaction
Jing Zhao, Xiangyi Meng, Jie Yang, et al.
Toxins
|
April 21, 2022
Protective Effects of Ferulic Acid on Deoxynivalenol-Induced Toxicity in IPEC-J2 Cells
Xiangyi Meng, Wenyan Yu, Nuo Duan, et al.
International Journal of Geriatric Psychiatry
|
February 20, 2014
Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis
Gustavo Alva, Richard Isaacson, Carl Sadowsky, et al.
International Journal of Geriatric Psychiatry
|
November 10, 2011
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy
Martin R Farlow, George T Grossberg, Xiangyi Meng, et al.
Dermatology (Basel, Switzerland)
|
May 30, 2019
Exploration of the Product of the 5-Point Investigator's Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis
Alice B Gottlieb, Rebecca Germino, Vivian Herrera, et al.
Page
of 14